Dr. Basu’s research focuses on understanding the health effects of dietary bioactive compounds, such as those found in tea, berries, and cocoa in modulating disease biomarkers in type 2 diabetes, hypertension, and related cardiovascular diseases. She has conducted several clinical trials focused on these foods, beverages, and dietary supplements among adults with the metabolic syndrome, type 2 diabetes, and cardiovascular risks. Dr. Basu also has extensive research interests in diabetes and nutritional epidemiology, and has published reports about prospective associations of lipid and lipoprotein biomarkers with diabetes vascular complications.
